APA

Patti F., Amato M. P., Trojano M., Bastianello S., Tola M. R., Picconi O., Cilia S., Cottone S., Centonze D. & Gasperini C. (20111121). Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. : Multiple sclerosis (Houndmills, Basingstoke, England).

Chicago

Patti F, Amato M P, Trojano M, Bastianello S, Tola M R, Picconi O, Cilia S, Cottone S, Centonze D and Gasperini C. 20111121. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. : Multiple sclerosis (Houndmills, Basingstoke, England).

Harvard

Patti F., Amato M. P., Trojano M., Bastianello S., Tola M. R., Picconi O., Cilia S., Cottone S., Centonze D. and Gasperini C. (20111121). Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. : Multiple sclerosis (Houndmills, Basingstoke, England).

MLA

Patti F, Amato M P, Trojano M, Bastianello S, Tola M R, Picconi O, Cilia S, Cottone S, Centonze D and Gasperini C. Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study. : Multiple sclerosis (Houndmills, Basingstoke, England). 20111121.